InvestorsHub Logo
icon url

sukus

01/27/24 2:14 PM

#667876 RE: exwannabe #667875

I am not surprised if this came from you Ex. Remember what Dr Bala called you multiple times in a day?

Should I repeat that here Ex? I guess not. 🤭
icon url

sukus

01/27/24 2:17 PM

#667878 RE: exwannabe #667875

Ex, you already lost the bet. But you don’t honor your promise that you gracefully won’t post any FUD again.

Now you want to bet again anf float that absurd idea that you seemed smarter than Dr Linda Liau and Dr Ashkan?

Of course, we know who we will believe in. 😅
icon url

flipper44

01/27/24 2:36 PM

#667882 RE: exwannabe #667875

You bet recently that DCVax-l could not be approved this year, and now you’re stating DCVax-l could be approved this year. Please take your profile and your inquirig profile and scram kid.

DR. Ashkan stated “a few months” from submission. There are new improved processes to speed approval at MHRA for high impact therapies in 2024. There is no reason to suspect DCVax-l will not be approved slightly ahead, equal to, or slightly behind Dr. Ashkan’s assessment. DCVax-l is considered a potential high impact therapy for GBM.
icon url

dennisdave

01/27/24 2:49 PM

#667884 RE: exwannabe #667875

But if I am wrong then later 2024 or early 2025 would be a reasonable timeline.

No if you are wrong you will leave this board as you said you would which is probably as of Aug 1 this year